Randomized, Open-Label Phase 3 Trial of Nivolumab versus Platinum-Doublet Chemotherapy in Early Stage NSCLC - Regional Cancer Care Associates LLC

Clinical Trials

Randomized, Open-Label Phase 3 Trial of Nivolumab versus Platinum-Doublet Chemotherapy in Early Stage NSCLC

Type of Cancer

Warning: implode(): Invalid arguments passed in /home/region33/public_html/wp-content/themes/regionalcancercenter/single-clinical-trials.php on line 42
Locations
Sponsor
Bristol Myers Squibb
Protocol Number
Bristol Myers Squibb CA209-816
Cancer Diagnosis
To Learn More Call
201-510-0910